A landmark study by Barcelona Institute for Global Health found that Brazil's Bolsa Família Program reduced TB cases and deaths among extreme poverty, indigenous groups, and improved healthcare access. The program's effects were stronger among the poorest and indigenous populations, with a 50-60% decrease in TB cases.
SourceBarcelona Institute for Global Health (ISGlobal)·JournalNature Medicine·TypeData/statistical analysis·DateJan 3, 2025
A new system can quickly identify emerging virus variants and provide information on their genetic changes, helping to understand why they spread differently in human populations. This enables the development of more effective vaccines and targeted treatments for diseases such as flu, COVID, and tuberculosis.
SourceUniversity of Cambridge·JournalNature·DateJan 1, 2025
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
John Howington, MD, MBA, FCCP, is the new President of CHEST, succeeding Neil S. Freedman, who will be President-Elect in 2026. Dr. Howington has extensive leadership experience and has published over 49 research publications.
A University of Toronto study discovered a new communication pathway between the gut and lung, highlighting the role of a little-known protozoan in shaping immune responses. The study found that this microbe can worsen airway inflammation in allergic asthma but provide protection against respiratory infections.
SourceUniversity of Toronto·JournalCell·TypeExperimental study·DateDec 19, 2024
A new study estimates that India will see over 62.4 million cases of tuberculosis in the next two decades, posing a significant burden on the country's health and economy. Scaling up existing treatment regimens could generate at least $28 billion in GDP gains, highlighting the need for increased investment in TB control measures.
SourcePLOS·JournalPLOS Medicine·TypeComputational simulation/modeling·DateDec 12, 2024
Researchers identified five fungi species with toxic effects against the bacterium, which disrupts cellular levels of thiols essential for bacterial survival. The findings support a strategy for developing treatment-shortening drugs by targeting biological processes maintaining thiol levels.
SourcePLOS·JournalPLOS Biology·TypeObservational study·DateDec 3, 2024
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
World health leaders outlined policy recommendations to tackle TB among refugee and migrant populations, leveraging successful experiences from regional countries. The report's ten strategies aim to guide stakeholders worldwide in achieving TB elimination for all.
Researchers at Tufts University discovered that TB bacteria maintain a consistent growth rate throughout their life cycle, defying expectations. The study also reveals new growth behaviors of TB bacteria, including the ability to grow from either end after division.
SourceTufts University·JournalNature Microbiology·DateNov 15, 2024
Researchers have uncovered why a relatively new antibiotic for tuberculosis works against multidrug-resistant strains by identifying deficiencies in a critical enzyme. This discovery could lead to improved treatments and drug development strategies, potentially allowing for lower doses or shorter treatment times.
SourceRutgers University·JournalNature Communications·TypeExperimental study·DateNov 13, 2024
Researchers identified a genetic weakness in drug-resistant Mycobacterium tuberculosis, allowing them to develop targeted drugs. This technology has the potential to combat other drug-resistant pathogens and prevent their spread.
SourceUniversity of Otago·JournalNature Communications·DateNov 13, 2024
A research team led by Dr. Bernd Meibohm is working on developing new treatments for tuberculosis that require fewer pills, shorter treatment periods, and reduce the risk of resistance. They aim to replace linezolid with Spectinamide 1810, a safer alternative that can be administered directly to the lungs.
SourceUniversity of Tennessee Health Science Center·DateNov 12, 2024
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
A new study published in The Lancet Child & Adolescent Health found that children living in areas with a high burden of tuberculosis have a consistently high annual risk of developing TB infection throughout childhood. By age 10, over 10% of children developed TB disease.
SourceBoston University School of Public Health·JournalThe Lancet Child & Adolescent Health·TypeObservational study·DateNov 5, 2024
Researchers discovered that tuberculosis alters liver metabolism and can push patients towards metabolic disease like diabetes. The study suggests undiagnosed TB could be a significant contributor to metabolic health issues.
SourceUniversity of Leicester·JournalPLOS Pathogens·TypeSystematic review·DateOct 21, 2024
Researchers at Texas Biomedical Research Institute developed a human cell culture model of alveolar macrophages, which helped make a key finding about the role of tumor necrosis factor (TNF) in tuberculosis (TB). The study found that TNF is critical to protect against TB but not other infectious diseases.
SourceTexas Biomedical Research Institute·JournalNature·DateOct 10, 2024
A new study has discovered a novel semi-synthetic compound derived from natural compounds that exhibits potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains. The compound, BPD-9, provides a promising chemical scaffold for developing new anti-tuberculosis drugs.
SourceAmerican Society for Microbiology·JournalMicrobiology Spectrum·DateOct 3, 2024
Sky-Watcher EQ6-R Pro Equatorial Mount
Sky-Watcher EQ6-R Pro Equatorial Mount provides precise tracking capacity for deep-sky imaging rigs during long astrophotography sessions.
African wormwood, a plant used for centuries to treat various illnesses, contains a compound that can kill the bacteria causing tuberculosis. Researchers have identified this compound, an O-methylflavone, as effective against both active and inactive states of the mycobacterium.
SourcePenn State·JournalJournal of Ethnopharmacology·TypeExperimental study·DateOct 2, 2024
Researchers at Texas Biomedical Institute have developed a TB therapy that does not interfere with combined antiretroviral therapy (cART) in patients with HIV. The host-directed therapy blocks an immune system protein and has shown improved control of TB when used with antibiotics.
SourceTexas Biomedical Research Institute·JournalJCI Insight·DateOct 1, 2024
After analyzing human immune cells and TB patients, researchers found that TCA metabolism plays a crucial role in DNA methylation. Adding an inhibitor of TCA activation reduced detrimental marks, suggesting epigenetic healing is possible. This discovery may lead to new treatment strategies for infectious diseases.
SourceBaylor College of Medicine·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 30, 2024
A recent study found that racial and ethnic tuberculosis (TB) disparities among US-born persons can result in significant long-term health consequences. The research indicates that these disparities can have substantial effects on the economy as well, potentially affecting TB elimination goals within the US.
SourceJAMA Network·JournalJAMA Network Open·DateSep 10, 2024
Researchers identified a genetic cause of TNF deficiency, which incapacitates a specific immune process in the lungs, leading to targeted and severe illness. This finding may upend long-held assumptions about the immune system and have far-reaching clinical implications.
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers discovered a non-virulent bacterium, Mycobacterium spongiae, that shares 80% of its genetic material with M. tuberculosis, shedding light on the disease's origins. The study provides valuable insights into the evolution and virulence of TB.
SourceUniversity of Melbourne·JournalPLOS Pathogens·TypeData/statistical analysis·DateAug 29, 2024
A subset of CD4 T cells create an anti-inflammatory environment within the lung tissue, protecting against TB reinfection by limiting bacterial growth and disease severity. The discovery complements previous research on protective immune T cells in controlling TB infection, suggesting a potential key to improving existing vaccines.
SourceUniversity of Pittsburgh·JournalImmunity·DateAug 29, 2024
A study analyzing 5.5 million EU/EEA infectious disease cases over 10 years found significant sex differences in notified male versus female cases for several diseases. The proportion of males ranged from 40-45% for pertussis and Shiga toxin-producing Escherichia coli infections to 75-80% for HIV/AIDS.
SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateAug 15, 2024
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
Researchers found that macrophages induce cancer cell apoptosis and then eat away dead cells after BCG vaccine injection in a new animal model. This breakthrough could lead to more effective bladder cancer treatments.
SourceChampalimaud Centre for the Unknown·JournalDisease Models & Mechanisms·TypeExperimental study·DateAug 8, 2024
Researchers found that close household contacts of people diagnosed with geographically restricted TB strains had a lower rate of infection and active TB disease compared to those exposed to widespread lineages. This suggests a shared evolution between humans and microbes, amplifying the risk for infection.
SourceHarvard Medical School·JournalNature Microbiology·TypeComputational simulation/modeling·DateAug 1, 2024
A new study by UC Davis researchers found that male gender and residency in large towns are the strongest risk factors for active TB progression in South Africa. Higher socioeconomic status, age, and migration history also impact active TB risk.
SourceUniversity of California - Davis·JournalPLOS Global Public Health·TypeData/statistical analysis·DateAug 1, 2024
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers have identified a group of molecules called callyaerins that can act against tuberculosis by targeting a specific membrane protein of the bacterium Mycobacterium tuberculosis. These substances inhibit bacterial growth without affecting human cells, offering a promising new approach to treating the disease.
SourceHeinrich-Heine University Duesseldorf·JournalCell Chemical Biology·DateJul 31, 2024
Human lung organoids can form lifelike models for tuberculosis infection, enabling the testing of anti-tuberculosis drugs. These models may also facilitate the development of host-directed therapies.
Scientists from Hackensack Meridian Health have identified a new potential pathway for developing vaccines against tuberculosis by targeting marginal zone B (MZB) cells, a natural response to TB infection. The discovery suggests that boosting MZB cell activity could provide reliable and durable protection against the disease.
SourceHackensack Meridian Health·JournalCell Reports·TypeExperimental study·DateJul 15, 2024
Researchers at Butantan Institute and collaborators developed a more potent version of the BCG vaccine, which protects against tuberculosis by inducing a strong immune response. The new formulation protected animals for a significantly longer period than conventional BCG.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·DateJul 3, 2024
Researchers at the University of the Witwatersrand have developed a modified BCG vaccine that shows enhanced protection against tuberculosis in mice. The new vaccine candidate could potentially replace or boost existing TB vaccines, providing a novel solution to the global health crisis.
SourceUniversity of the Witwatersrand·JournaleLife·TypeObservational study·DateJun 25, 2024
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Researchers have designed a novel 3D hydrogel culture system that accurately mimics the mammalian lung environment, allowing for the study of tuberculosis bacteria infection and therapeutics. The system successfully tracks infection progression and demonstrates the efficacy of pyrazinamide in clearing out TB bacteria.
SourceIndian Institute of Science (IISc)·JournalAdvanced Healthcare Materials·DateJun 25, 2024
Scientists have developed a new method to detect antibiotics in finger sweat, showing high accuracy for tuberculosis treatment monitoring. The technique allows for less invasive testing, making it easier to monitor treatment and preventing drug-resistant TB.
SourceUniversity of Surrey·JournalInternational Journal of Antimicrobial Agents·TypeExperimental study·DateJun 24, 2024
The American College of Chest Physicians' CHEST Critical Care and CHEST Pulmonary journals have been indexed with the Directory of Open Access Journals (DOAJ), enhancing their open access content's accessibility and usage. The indexation is attributed to strong editorial boards led by Hayley Gershengorn and Matthew Miles.
SourceAmerican College of Chest Physicians·JournalCHEST Critical Care·DateMay 23, 2024
A new study suggests that countries should prioritize tuberculosis treatment for exposed individuals with evidence of TB infection, regardless of age—except in high-burden settings, where all exposed individuals should be considered for treatment. Preventive treatment can stop latent TB infections from developing into deadly TB disease.
SourceBoston University School of Public Health·JournalThe Lancet Respiratory Medicine·TypeSystematic review·DateMay 8, 2024
New therapies aim to strengthen the body's immune responses and restore antimicrobial functions to combat TB. Researchers have identified small molecule compounds that reduce Mtb growth inside immune cells by up to 50-75%, suggesting a potential complement to standard therapy.
SourceEuropean Society of Clinical Microbiology and Infectious Diseases·DateApr 26, 2024
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
Researchers found that undernourished household contacts were three times more likely to progress to TB disease than well-nourished individuals. The study suggests that undernutrition fails to contain the infection when it occurs, leading to increased risk of severe illness and death.
SourceBoston University School of Medicine·JournalClinical Infectious Diseases·TypeObservational study·DateApr 23, 2024
Researchers uncover how tuberculosis infection drives excessive inflammation in the lungs by activating neutrophils. Targeting neutrophils could lead to new therapies for TB treatment, potentially reducing antibiotic-resistant cases.
SourceTrinity College Dublin·JournalInternational Journal of Molecular Sciences·TypeExperimental study·DateApr 16, 2024
A study of tens of thousands of individuals found that post-TB lung disease is a significant global challenge. TB survivors experience restrictive lung damage and airflow obstruction, reducing their ability to breathe efficiently and increasing the risk of cardiovascular and respiratory diseases.
SourceEuropean Society of Clinical Microbiology and Infectious Diseases·DateApr 14, 2024
A study found that structural racism is largely to blame for disparities in tuberculosis (TB) incidence among the U.S.-born population. Researchers analyzed national TB registry data and found that TB incidence ratios were higher for certain racial and ethnic groups, with greater relative disparities among females.
SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateApr 1, 2024
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A population-wide observational study found an association between tuberculosis (TB) and a higher incidence of various cancers. TB patients were more likely to be diagnosed with lung, blood, gynaecological, colorectal, thyroid, oesophagus, and stomach cancers compared to the general population.
SourceEuropean Society of Clinical Microbiology and Infectious Diseases·DateMar 31, 2024
A new study finds that BCG vaccination reduces TB transmission in cattle by almost 90%. Vaccinated cows also develop significantly fewer visible signs of TB than unvaccinated ones. The vaccine has the potential to control bovine tuberculosis and put herds on a pathway towards elimination.
SourceUniversity of Cambridge·JournalScience·DateMar 28, 2024
A new study published in Microbiology Spectrum shows that an enzymatic cocktail can effectively kill a variety of mycobacterial species, including those causing tuberculosis. The research delivers the enzymes inside host macrophages where mycobacteria grow, increasing efficacy and reducing toxicities associated with current treatments.
SourceAmerican Society for Microbiology·JournalMicrobiology Spectrum·DateMar 27, 2024
Researchers at Massachusetts General Hospital successfully repurposed approved drugs to improve drug delivery to tuberculosis bacteria, promoting anti-bacterial host responses and improving health outcomes. The study found that combining bevacizumab and losartan enhanced TB drug delivery and reduced bacterial burden in rabbits with TB.
SourceMassachusetts General Hospital·JournalProceedings of the National Academy of Sciences·DateMar 27, 2024
Researchers have developed new recommendations for optimizing TB screening programs in low-incidence countries. Screening high-risk groups, such as migrants and vulnerable populations, is a cost-effective approach that detects the disease early and prevents transmission.
SourceGermans Trias i Pujol Research Institute·JournalEurosurveillance·TypeLiterature review·DateMar 25, 2024
Apple iPad Pro 11-inch (M4)
Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.
Researchers have identified a combination of medications that may improve blood flow within granulomas, benefiting drug delivery and reducing bacterial burden in tuberculosis-infected rabbits. The study leverages decades of cancer research to study tuberculosis-affected lung tissue and improves treatment.
SourceUniversity of Notre Dame·JournalProceedings of the National Academy of Sciences·DateMar 25, 2024
A systematic review by Gogichadze et al. suggests that active pulmonary TB screening programs targeting vulnerable populations in low-TB-incidence countries are cost-effective. The authors conclude that screening immigrants and other high-risk groups is a viable approach to detecting latent infections.
SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeSystematic review·DateMar 22, 2024
Researchers have developed a new framework for classifying tuberculosis (TB) that replaces the traditional binary approach with four disease states: clinical, subclinical, infectious, and non-infectious. The International Consensus for Early TB (ICE-TB) framework aims to improve diagnosis and treatment of early-stage TB, which has hist...
SourceUniversity College London·JournalThe Lancet Respiratory Medicine·TypeSurvey·DateMar 22, 2024
Scientists have discovered six proteins that can accurately diagnose tuberculosis (TB). The breakthrough study paves the way for a simple blood test to detect the bacteria, which could prevent millions of cases annually. TB is the world's deadliest infectious disease, killing over one million people each year.
SourceUniversity of Southampton·JournalJournal of Clinical Investigation·TypeRandomized controlled/clinical trial·DateMar 22, 2024
Tulane University researchers have developed a CRISPR-based platform for diagnosing nontuberculous mycobacteria (NTM) infections, allowing for accurate results in as little as two hours. The blood test can identify over 93% of patients with an NTM infection, enabling rapid treatment plans and reducing the risk of complications.
SourceTulane University·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateMar 14, 2024
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
Research on over 600,000 TB cases reveals 80% have no persistent cough, delaying diagnoses and transmission, with high infection rates among symptomless individuals. The study suggests rethinking current diagnostic practices for more effective TB identification.
SourceAmsterdam University Medical Center·JournalThe Lancet Infectious Diseases·TypeMeta-analysis·DateMar 12, 2024
A study by Amsterdam UMC and University of Cape Town found that Mycobacterium tuberculosis is present in the respiratory aerosol of 90% of suspected TB patients, including those with negative sputum tests. This raises concerns about unknowingly transmitting infection and highlights the complexity of TB transmission.
SourceAmsterdam University Medical Center·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateMar 11, 2024
The Access to Advanced Health Institute (AAHI) has received $12.7 million to develop a novel immune-stimulating adjuvant formulation, NanoAlum, which aims to improve vaccine protection against complex diseases like tuberculosis and influenza.
SourceAccess to Advanced Health Institute·DateMar 7, 2024
A network of African scientists has secured funding to develop new drugs for malaria and TB, two major diseases affecting the continent. The Grand Challenges Africa Drug Discovery Accelerator Programme will support leading research efforts on these diseases.
Researchers at Weill Cornell Medicine found that patients with drug-resistant tuberculosis (TB) respond similarly to those with drug-sensitive TB when treated with bedaquiline-based second-line medications. The study suggests that treatment duration for drug-resistant TB may be shortened, potentially reducing mortality rates.
SourceWeill Cornell Medicine·JournalThe Journal of Infectious Diseases·DateFeb 27, 2024
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Researchers at McGill University Health Centre discovered that a century-old BCG vaccine can provide cross-protection against influenza A virus and COVID-19 by inducing trained immunity. The study's findings have significant implications for developing vaccines against emerging respiratory viruses.
SourceMcGill University·JournalNature Immunology·DateFeb 26, 2024
Researchers found that an imbalance of CD4+ T cells in the lungs can exacerbate tuberculosis, leading to increased disease severity and reduced survival rates. Removing a specific receptor that recognizes extracellular ATP can improve the response of these T cells and potentially lead to new therapeutic interventions.
SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalCell Reports·DateFeb 8, 2024
A new study from the University of Cincinnati finds that being in prison is a significant driver of multidrug-resistant tuberculosis (MDR-TB) transmission. The researchers identified molecular resistance patterns and defined recent transmissions, highlighting the need for targeted interventions to control the MDR-TB epidemic in prisons.
SourceUniversity of Cincinnati·JournalThe Lancet Regional Health - Americas·TypeObservational study·DateFeb 8, 2024
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
Researchers at La Jolla Institute for Immunology have identified 137 unique T cell epitopes targeted by the immune system in patients with active TB. These findings may lead to the development of new diagnostics and therapies for the disease, which affects over 1.3 million people worldwide.
SourceLa Jolla Institute for Immunology·JournalNature Communications·TypeExperimental study·DateFeb 6, 2024
The University of Texas at Arlington is advancing its understanding of deadly disease tuberculosis (TB) with a new research project led by associate professor Kayunta Johnson-Winters. The project aims to understand why certain types of Mycobacterium tuberculosis bacteria do not respond to treatments.